TCF1-positive and TCF1-negative TRM CD8 T cell subsets and cDC1s orchestrate melanoma protection and immunotherapy response.
De León-Rodríguez SG, Aguilar-Flores C, Gajón JA, Juárez-Flores Á, Mantilla A, Gerson-Cwilich R, Martínez-Herrera JF, Villegas-Osorno DA, Gutiérrez-Quiroz CT, Buenaventura-Cisneros S, Sánchez-Prieto MA, Castelán-Maldonado E, Rivera Rivera S, Fuentes-Pananá EM, Bonifaz LC.
De León-Rodríguez SG, et al. Among authors: mantilla a.
J Immunother Cancer. 2024 Jul 5;12(7):e008739. doi: 10.1136/jitc-2023-008739.
J Immunother Cancer. 2024.
PMID: 38969523
Free PMC article.